4DMedical secures regulatory approval for CTVQ in Canada
Filed with ASX · · 3 pages · English
Summary by 6ix AI
4DMedical Ltd. has announced that it has received regulatory approval for its CT:VQ™ imaging technology in Canada, which allows for immediate commercial deployment through its partnership with Philips. The company expects that CT:VQ™ will rapidly capture market share and potentially replace traditional nuclear VQ scans due to its technological advantages.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from 4DMedical
- 4DMedical secures $30.2 million with options underwrite
- University of Miami adopts CTVQ
- 4DMedical secures US$10m CTVQ orders in Philips deal
- CTVQ commercial rollout commences at Stanford
- 4DMedical secures $22.6 million via exercise of options
Later from 4DMedical
- Cleveland Clinic adopts CTVQ
- UC San Diego Health adopts CTVQ
- Trading Halt
- 4DMedical completes $150 million institutional placement
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical